Manchester Financial Inc Neogenomics Inc Transaction History

Manchester Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$36.62 - $51.69 $1,391 - $1,964	-38 Closed	0 $0
Q1 2020 Apr 20, 2020	SELL	$20.5 - $34.53 $11,275 - $18,991	-550 Reduced 93.54%	38 $1,000
Q4 2019 Jan 17, 2020	BUY	$18.96 - $29.84 $11,148 - $17,545	588 New	588 $17,000
Q3 2019 Oct 09, 2019	SELL	$19.12 - $26.24 $726 - $997	-38 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$19.57 - $24.1 $743 - $915	38 New	38 $1,000

279

127M

581K

107K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.78B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.